BR9911601A - Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores - Google Patents

Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores

Info

Publication number
BR9911601A
BR9911601A BR9911601-4A BR9911601A BR9911601A BR 9911601 A BR9911601 A BR 9911601A BR 9911601 A BR9911601 A BR 9911601A BR 9911601 A BR9911601 A BR 9911601A
Authority
BR
Brazil
Prior art keywords
neisseria meningitidis
protective antibodies
polypeptides
antigenic polypeptides
corresponding polynucleotides
Prior art date
Application number
BR9911601-4A
Other languages
English (en)
Inventor
Jean-Louis Ruelle
Johannes Petrus Mari Tommassen
Original Assignee
Smithkline Beecham Biolog
Univ Utrecht
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog, Univ Utrecht filed Critical Smithkline Beecham Biolog
Publication of BR9911601A publication Critical patent/BR9911601A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"POLIPEPTìDIOS ANTIGêNICOS DE NEISSERIA MENINGITIDIS, POLINUCLEOTìDEOS CORRESPONDENTES E ANTICORPOS PROTETORES"<D>. A invenção fornece polipeptídios BASB030 de Neisseria meningitidis e polinucleotídeos codificando polipeptídios BASB030 e métodos para a produção desses polipeptídios por técnicas recombinantes. Também são fornecidos usos antibióticos, diagnósticos, profiláticos e terapêuticos dos mesmos.
BR9911601-4A 1998-05-26 1999-05-26 Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores BR9911601A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9811260.0A GB9811260D0 (en) 1998-05-26 1998-05-26 Novel compounds
PCT/EP1999/003603 WO1999061620A2 (en) 1998-05-26 1999-05-26 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies

Publications (1)

Publication Number Publication Date
BR9911601A true BR9911601A (pt) 2001-02-06

Family

ID=10832701

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911601-4A BR9911601A (pt) 1998-05-26 1999-05-26 Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores

Country Status (21)

Country Link
US (2) US6994860B1 (pt)
EP (1) EP1080198B1 (pt)
JP (1) JP2002516105A (pt)
KR (1) KR20010052409A (pt)
CN (1) CN1322249A (pt)
AT (1) ATE312921T1 (pt)
AU (1) AU761185B2 (pt)
BR (1) BR9911601A (pt)
CA (1) CA2329269A1 (pt)
DE (1) DE69928925T2 (pt)
ES (1) ES2253893T3 (pt)
GB (1) GB9811260D0 (pt)
HU (1) HUP0102730A2 (pt)
IL (1) IL139696A0 (pt)
MX (1) MXPA00011764A (pt)
NO (1) NO20005952L (pt)
NZ (1) NZ508324A (pt)
PL (1) PL345793A1 (pt)
TR (1) TR200003467T2 (pt)
WO (1) WO1999061620A2 (pt)
ZA (1) ZA200006872B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081244B2 (en) 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
GB0011108D0 (en) * 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
PL399492A1 (pl) 2002-08-02 2012-11-19 Glaxosmithkline Biologicals S.A. Szczepionka
GB0419918D0 (en) * 2004-09-08 2004-10-13 Imp College Innovations Ltd Vaccine
CN103002910A (zh) 2010-03-10 2013-03-27 葛兰素史密丝克莱恩生物有限公司 疫苗组合物
WO2012059593A1 (en) * 2010-11-05 2012-05-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccines for preventing meningococcal infections
JP2015524418A (ja) 2012-07-27 2015-08-24 アンスティテュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 血管内皮細胞への髄膜炎菌の線毛媒介接着の受容体としてのcd147
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
JPH01125328A (ja) * 1987-07-30 1989-05-17 Centro Natl De Biopreparados 髄膜炎菌ワクチン
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques

Also Published As

Publication number Publication date
CA2329269A1 (en) 1999-12-02
NZ508324A (en) 2002-07-26
AU4500699A (en) 1999-12-13
WO1999061620A3 (en) 2000-03-02
JP2002516105A (ja) 2002-06-04
CN1322249A (zh) 2001-11-14
EP1080198A2 (en) 2001-03-07
US6994860B1 (en) 2006-02-07
EP1080198B1 (en) 2005-12-14
GB9811260D0 (en) 1998-07-22
IL139696A0 (en) 2002-02-10
ATE312921T1 (de) 2005-12-15
ZA200006872B (en) 2002-01-23
AU761185B2 (en) 2003-05-29
PL345793A1 (en) 2002-01-02
WO1999061620A2 (en) 1999-12-02
HUP0102730A2 (hu) 2001-11-28
DE69928925T2 (de) 2006-07-20
NO20005952L (no) 2001-01-18
NO20005952D0 (no) 2000-11-24
DE69928925D1 (de) 2006-01-19
KR20010052409A (ko) 2001-06-25
ES2253893T3 (es) 2006-06-01
MXPA00011764A (es) 2003-04-25
TR200003467T2 (tr) 2001-04-20
US20060189792A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
BR9910396A (pt) Polinucleotìdeo(s) e polipeptìdeos basb029 a partirde neisseria meningitidis
BR9911601A (pt) Polipeptìdios antigênicos de neisseria meningitidis, polinucleotìdeos correspondentes e anticorpos protetores
PT1112366E (pt) Polinucleotideos e polipeptideos basb033 da neisseria meningitidis e suas utilizacoes
EP2163628A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
BR9911773A (pt) Compostos de moraxella catarrhalis
BR9914492A (pt) Polipeptìdos basb034 de moraxella catarrhalis e usos dos mesmos
GB9809683D0 (en) Novel compounds
DE69921649D1 (de) Moraxella catarrhalis pilq proteine
WO2000043519A3 (en) Neisseria meningitidis polypeptides
BR9911609A (pt) Proteìnas e genes de moraxella catarrhalis, antìgenos, anticorpos e usos
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
WO2000034482A3 (en) Novel compounds derived from neisseria meningitidis
GB9918208D0 (en) Novel compounds
GB0025170D0 (en) Novel compounds
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
PT1204752E (pt) Polipéptidos imunogénicos derivados de moraxella catarrhalis e suas utilizações
GB9918302D0 (en) Novel compounds
DE60019613D1 (de) Moraxella catarrhalis antigen basb120
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
WO2001009331A3 (en) Moraxella catarrhalis antigen basb125
GB9914945D0 (en) Novel compounds
WO2001009337A3 (en) Moraxella catarrhalis antigens basb122 and basb124
WO2001009330A3 (en) Moraxella catarrhalis antigen basb121

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.